@article{0e1827e6c6bc4c0d901367e0236e39e7,
title = "Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression",
author = "J. Ojha and C. Secreto and K. Rabe and J. Ayres-Silva and R. Tschumper and Dyke, {D. V.} and S. Slager and R. Fonseca and T. Shanafelt and N. Kay and E. Braggio",
note = "Funding Information: RF has received a patent for the prognostication of MM based on genetic categorization of the disease. He has received consulting fees from Medtronic, Otsuka, Celgene, Genzyme, BMS, Lilly, Onyx, Binding Site, Millenium and AMGEN. He also has sponsored research from Cylene and Onyx. TS was supported by fundings from Hospira, Genentech, Glaxo-Smith-Kline, Jannsen, Celgene and Cephalon. The remaining authors declare no conflcit of interest. Funding Information: EB is a recipient of the Marriott Specialized Workforce Development Awards in Individualized Medicine and the Henry Predolin Foundation Career Development Award. This work was supported by the Henry Predolin Foundation and grant NIH-CA95241.",
year = "2014",
month = dec,
day = "11",
doi = "10.1038/leu.2014.226",
language = "English (US)",
volume = "28",
pages = "2395--2398",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "12",
}